At a glance
ClinicalIndex Comparison RecordN/ACompleted· 579 enrolled
Drug / intervention
Lipacreondrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Special Investigation of LipaCreon on Long-term Use in Patients With Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis, Pancreatectomy and Other Conditions Except Cystic Fibrosis
In Brief
An observational study evaluating Lipacreon for Exocrine Pancreatic Insufficiency and 2 related conditions. Completed, enrolled 579 participants across 189 sites.
Detailed Summary
This study aims at collecting the information related to the safety and effectiveness in the pancreatic exocrine insufficiency patients receiving the treatment with LipaCreon for a long term in order to evaluate the effective and safe use of LipaCreon.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2011
First PostedSep 2011
Primary CompletionJan 2015
Study CompletionApr 2015
TodayJul 2026
First PostedSep 2, 2011
Enrollment StartSep 1, 2011
Primary CompletionJan 1, 2015
Study CompletionApr 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 14.8 years ago
Interventions
Lipacreondrug
This study was an observational study and no intervention was specified